Literature DB >> 33641586

Next generation sequencing for biliary tract cancers.

Timothy P DiPeri1, Milind M Javle2, Funda Meric-Bernstam1,3.   

Abstract

Entities:  

Keywords:  Biliary tract cancer; cholangiocarcinoma; gallbladder cancer; precision oncology; ✚-next-generation sequencing

Mesh：

Year:  2021        PMID： 33641586      PMCID： PMC8172427          DOI： 10.1080/17474124.2021.1896967

Source DB:  PubMed          Journal:  Expert Rev Gastroenterol Hepatol        ISSN： 1747-4124            Impact factor:   3.869


× No keyword cloud information.
  19 in total

1.  Genomic spectra of biliary tract cancer.

Authors:  Hiromi Nakamura; Yasuhito Arai; Yasushi Totoki; Tomoki Shirota; Asmaa Elzawahry; Mamoru Kato; Natsuko Hama; Fumie Hosoda; Tomoko Urushidate; Shoko Ohashi; Nobuyoshi Hiraoka; Hidenori Ojima; Kazuaki Shimada; Takuji Okusaka; Tomoo Kosuge; Shinichi Miyagawa; Tatsuhiro Shibata
Journal:  Nat Genet       Date:  2015-08-10       Impact factor: 38.330

2.  Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for Intervention.

Authors:  Maeve A Lowery; Ryan Ptashkin; Emmet Jordan; Michael F Berger; Ahmet Zehir; Marinela Capanu; Nancy E Kemeny; Eileen M O'Reilly; Imane El-Dika; William R Jarnagin; James J Harding; Michael I D'Angelica; Andrea Cercek; Jaclyn F Hechtman; David B Solit; Nikolaus Schultz; David M Hyman; David S Klimstra; Leonard B Saltz; Ghassan K Abou-Alfa
Journal:  Clin Cancer Res       Date:  2018-05-30       Impact factor: 12.531

3.  TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion-Positive Intrahepatic Cholangiocarcinoma.

Authors:  Lipika Goyal; Lei Shi; Leah Y Liu; Ferran Fece de la Cruz; Jochen K Lennerz; Srivatsan Raghavan; Ignaty Leschiner; Liudmila Elagina; Giulia Siravegna; Raymond W S Ng; Phuong Vu; Krushna C Patra; Supriya K Saha; Raul N Uppot; Ron Arellano; Stephanie Reyes; Takeshi Sagara; Sachie Otsuki; Brandon Nadres; Heather A Shahzade; Ipsita Dey-Guha; Isobel J Fetter; Islam Baiev; Emily E Van Seventer; Janet E Murphy; Cristina R Ferrone; Kenneth K Tanabe; Vikram Deshpande; James J Harding; Rona Yaeger; Robin K Kelley; Alberto Bardelli; A John Iafrate; William C Hahn; Cyril H Benes; David T Ting; Hiroshi Hirai; Gad Getz; Dejan Juric; Andrew X Zhu; Ryan B Corcoran; Nabeel Bardeesy
Journal:  Cancer Discov       Date:  2019-05-20       Impact factor: 39.397

4.  Biliary cancer: Utility of next-generation sequencing for clinical management.

Authors:  Milind Javle; Tanios Bekaii-Saab; Apurva Jain; Ying Wang; Robin Katie Kelley; Kai Wang; Hyunseon C Kang; Daniel Catenacci; Siraj Ali; Sunil Krishnan; Daniel Ahn; Andrea Grace Bocobo; Mingxin Zuo; Ahmed Kaseb; Vincent Miller; Philip J Stephens; Funda Meric-Bernstam; Rachna Shroff; Jeffrey Ross
Journal:  Cancer       Date:  2016-09-13       Impact factor: 6.860

Review 5.  Circulating Tumor DNA in Biliary Tract Cancer: Current Evidence and Future Perspectives.

Authors:  Alessandro Rizzo; Angela Dalia Ricci; Simona Tavolari; Giovanni Brandi
Journal:  Cancer Genomics Proteomics       Date:  2020 Sep-Oct       Impact factor: 4.069

6.  Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study.

Authors:  Ghassan K Abou-Alfa; Vaibhav Sahai; Antoine Hollebecque; Gina Vaccaro; Davide Melisi; Raed Al-Rajabi; Andrew S Paulson; Mitesh J Borad; David Gallinson; Adrian G Murphy; Do-Youn Oh; Efrat Dotan; Daniel V Catenacci; Eric Van Cutsem; Tao Ji; Christine F Lihou; Huiling Zhen; Luis Féliz; Arndt Vogel
Journal:  Lancet Oncol       Date:  2020-03-20       Impact factor: 41.316

7.  Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial.

Authors:  Vivek Subbiah; Ulrik Lassen; Elena Élez; Antoine Italiano; Giuseppe Curigliano; Milind Javle; Filippo de Braud; Gerald W Prager; Richard Greil; Alexander Stein; Angelica Fasolo; Jan H M Schellens; Patrick Y Wen; Kert Viele; Aislyn D Boran; Eduard Gasal; Paul Burgess; Palanichamy Ilankumaran; Zev A Wainberg
Journal:  Lancet Oncol       Date:  2020-08-17       Impact factor: 41.316

8.  Exome sequencing of liver fluke-associated cholangiocarcinoma.

Authors:  Choon Kiat Ong; Chutima Subimerb; Chawalit Pairojkul; Sopit Wongkham; Ioana Cutcutache; Willie Yu; John R McPherson; George E Allen; Cedric Chuan Young Ng; Bernice Huimin Wong; Swe Swe Myint; Vikneswari Rajasegaran; Hong Lee Heng; Anna Gan; Zhi Jiang Zang; Yingting Wu; Jeanie Wu; Ming Hui Lee; DaChuan Huang; Pauline Ong; Waraporn Chan-on; Yun Cao; Chao-Nan Qian; Kiat Hon Lim; Aikseng Ooi; Karl Dykema; Kyle Furge; Veerapol Kukongviriyapan; Banchob Sripa; Chaisiri Wongkham; Puangrat Yongvanit; P Andrew Futreal; Vajarabhongsa Bhudhisawasdi; Steve Rozen; Patrick Tan; Bin Tean Teh
Journal:  Nat Genet       Date:  2012-05-06       Impact factor: 38.330

9.  Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study.

Authors:  Ghassan K Abou-Alfa; Teresa Macarulla; Milind M Javle; Robin K Kelley; Sam J Lubner; Jorge Adeva; James M Cleary; Daniel V Catenacci; Mitesh J Borad; John Bridgewater; William P Harris; Adrian G Murphy; Do-Youn Oh; Jonathan Whisenant; Maeve A Lowery; Lipika Goyal; Rachna T Shroff; Anthony B El-Khoueiry; Bin Fan; Bin Wu; Christina X Chamberlain; Liewen Jiang; Camelia Gliser; Shuchi S Pandya; Juan W Valle; Andrew X Zhu
Journal:  Lancet Oncol       Date:  2020-05-13       Impact factor: 41.316

10.  Whole-exome sequencing reveals the origin and evolution of hepato-cholangiocarcinoma.

Authors:  Anqiang Wang; Liangcai Wu; Jianzhen Lin; Longzhe Han; Jin Bian; Yan Wu; Simon C Robson; Lai Xue; Yunxia Ge; Xinting Sang; Wenze Wang; Haitao Zhao
Journal:  Nat Commun       Date:  2018-03-01       Impact factor: 14.919
View more
  2 in total

1.  Benchmarking Outcomes after Ablative Radiotherapy for Molecularly Characterized Intrahepatic Cholangiocarcinoma.

Authors:  Brian De; Ibrahim Abu-Gheida; Aashini Patel; Sylvia S W Ng; Mohamed Zaid; Connor P Thunshelle; Dalia Elganainy; Kelsey L Corrigan; Michael K Rooney; Milind Javle; Kanwal Raghav; Sunyoung S Lee; Jean-Nicolas Vauthey; Ching-Wei D Tzeng; Hop S Tran Cao; Ethan B Ludmir; Bruce D Minsky; Grace L Smith; Emma B Holliday; Cullen M Taniguchi; Albert C Koong; Prajnan Das; Eugene J Koay
Journal:  J Pers Med       Date:  2021-12-01

Review 2.  Treatment of Resectable Gallbladder Cancer.

Authors:  Eduardo A Vega; Sebastian Mellado; Omid Salehi; Richard Freeman; Claudius Conrad
Journal:  Cancers (Basel)       Date:  2022-03-10       Impact factor: 6.639
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.